Flyway Health Research
Independent, claims-based healthcare research built on 330M+ lives of medical and pharmacy data.
The Moments That Matter After a gMG FlareClaims and patient survey data point to two moments after a flare that shape whether treatment changes.The ATTR-CM Diagnosis GapThe gap starts at the diagnosis, not at the pharmacy.The Next Buy-and-Bill WriterBuy-and-bill belongs to the office, not to the prescriber.Two Prescribers, Different Conversion RatesThe gap is not between accounts. It is inside them.HIV ART Disengagement50,000 HIV Patients Are Still Seeing Their Doctor. They Haven't Filled ART in Six Months.CVS Zepbound Forced SwitchWhat Happened to 72,245 Zepbound PatientsAD Market DynamicsDupixent Patients Don't Switch. They Disappear.NSCLC Specialty Pharmacy ComparisonSame Drug. Different Pharmacy. Different Outcome.cGVHD Therapy SequencingSame Disease. Different Prior Therapy. Different Choice.
About our research
Flyway's research is independent and claims-based, built on 330M+ lives of medical and pharmacy data. No manufacturer funds these analyses.
Research methodologyResearch team